Daré Bioscience, Inc.DARENASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank43
3Y CAGR-69.0%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-69.0%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.21-100.0%
20242709.59+26376.0%
202310.23+45.8%
20227.02-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-100.0%
2016307.41-